Flatiron Health
Overview
Oncology-focused health technology company that curates EHR-derived, research-grade real-world data from a national network of community oncology practices and academic centers using its OncoEMR software. Offers end-to-end RWE solutions from data licensing to analytic and scientific services for cancer drug development.
Notable
Acquired by Roche in 2018 for $1.9B; its datasets underpin numerous FDA regulatory submissions and peer-reviewed oncology RWE publications; remains open to external pharma partners.
Key services
- oncology EHR-derived real-world data
- chart abstraction and data curation
- external control arms
- RWE study design and analytics
- regulatory-grade evidence services
Subcategories
Verified Reviews
No verified reviews yet — are you a customer of Flatiron Health? Share your experience in a short, confidential interview.
Share your experience